Nonpartisan civic infrastructure
AllCiv·Legis1
·

S. 724

BillFederalSenateIn Committee
A bill to amend the Controlled Substances Act to establish additional registration requirements for prescribers of opioids, and for other purposes.
About This Bill
Committee
Latest Action · March 7, 2019
Read twice and referred to the Committee on the Judiciary.
Congress
116th (2019–2021)
Introduced
March 7, 2019
Cosponsors (1)
0D 1R
View PDF ↗

Summary

Highlight any text to annotate
John S. McCain Opioid Addiction Prevention Act This bill establishes a new registration requirement for practitioners who are licensed to prescribe controlled substances in schedule II, III, or IV. Specifically, a practitioner must agree to limit the supply of opioids prescribed for the initial treatment of acute pain, as a condition of obtaining or renewing a registration through the Drug Enforcement Administration. An opioid that is approved and prescribed for the treatment of addiction is not subject to the limit.

Take Action

Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.